los angeles/washington americans grow alarm rise prescription drug cost pressure new u.s. administration congress take action pharmaceutical price industry executives healthcare experts say drugmaker stock batter recent months soar week republican presidential candidate donald trump victory democratic rival hillary clinton vow take pharmaceutical price gouge pundits predict democrats would gain control senate give strong hand republican sweep congress eliminate fear boost chance measure corporate tax reform would benefit industry however vote change key dynamic u.s. consumers pay cost drug high health insurance deductibles copayments make sensitive manufacturer price hike recently sixfold increase price mylan nv epipen stoke outrage families rely lifesaving allergy shoot prompt investigations state attorneys general congress manufacturer sharply raise price drug headline think matter party office say sandra hunt principal pricewaterhousecooper health industry practice republican lawmakers take drug price alongside democrats republicans senator charles grassley iowa chair senate judiciary committee representative jason chaffetz chair house committee oversight government reform lead inquiries mylan epipen price strong majority republican voters want congress address drug price say john rother president ceo national coalition health care campaign low price october kaiser family foundation survey show 74 percent respondents say make drug chronic condition affordable top health care priority federal government among republican respondents 68 percent put drug price top priority poll conduct harvard t.h chan school public health find 64 percent voters include 78 percent likely clinton voters 48 percent trump supporters believe federal government able limit pharmaceutical drug price hike trump republican leaders vow repeal president barack obama healthcare reform law know obamacare extend medical insurance 20 million americans despite complaints obamacare insurance premium increase 37 percent kaiser poll respondents say overturn high priority chaffetz evaluate next step drug price issue next congress convene aide say representative grassley say would press forward schedule nov. 30 hear mylan epipen price u.s. always country support innovation ... hope remain say pascal soriot chief executive astrazeneca plc sell drug like cholesterol-fighter crestor also believe continue deal price ressures clinton proposals curb drug price include cap consumers monthly out-of-pocket cost past trump suggest allow government medicare health program seniors negotiate price make easy import drug countries sell less trump administration also could provide extra fund u.s. food drug administration speed approval generic drug still tend cost far less brand name equivalents health policy experts say capital alpha partner analyst kim monk research note wednesday say expect advisors congress steer trump toward republican-oriented ideas include price drug base relative health benefit require disclosure price detail consumer advocate rother cite fair drug price act introduce september senators john mccain arizona republican tammy baldwin wisconsin democrat potential vehicle federal action bill would require manufacturers explain annual price increase 10 percent bipartisan bill consistent traditional republican health policy base transparency competition rother say california voters tuesday reject ballot measure would require drugmakers provide state health plan discount similar give u.s. department veterans affairs va pay low price country drugmakers spend 106 million campaign defeat measure similar measure go ohio voters back trump election next november coalition behind california proposition wednesday urge legislators come comprehensive solution low sky-rocketing drug price u.s. consumers want trump congress take drug price